Inhibitors against Factor VIII Associated with the Use of Interferon-alpha and Fludarabine

References
1 Roberts HR, Sallah S. Immunology of inhibitors to clotting factors with emphasis on factor VIII inhibitors. In. Silbertstein LE. ed. Autoimmune disorders of blood. Bethesda, MD: American Association of Blood Banks; 1996: 155-70.
2 Hoyer LW. Factor VIII inhibitors. Curr Opin Hematol 1995; 2: 365-71.
3 Lottenberg R, Kentro TB, Kitchens CS. Acquired hemophilia: a natural history of 16 patients with factor VIII inhibitors receiving little or no therapy. Arch Intern Med 1987; 147: 1077-81.
4 Sallah S, Wan JY. Inhibitors against factor VIII in patients with cancer: analysis of 41 patients. Cancer 2001; 81: 1676-774.
5 Green D, Lechner K. A survey of 215 non-hemophiliac patients with inhibitors to factor VIII. Thromb Haemost 1981; 45: 200-3.
6 Mauser-Bunschoten EP, Damen M, Reesnik H, Rosendaal G, Chamuleau RAFM, van der Berg HM. Formation of antibodies to factor VIII in patients with hemophilia A treated with interferon for chronic hepatitis C. Ann Intern Med 1996; 125: 297-9.
7 Tiplady CW, Hamilton PJ, Galloway MJ. Acquired hemophilia complicating the remission of a patient with high grade non-Hodgkin’s lymphoma treated by fludarabine. Clin Lab Haematol 2000; 22: 163-5.
8 Kasper CR, Aledort LM, Counts RB, Edson JR, Fratantoni J, Green D, Hampton JW, Hilgartner MW, Lazerson J, Levine PH, McMillan CW, Pool JG, Shapiro SS, Shulman NR, Van Eys J. A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 1975; 34: 869-76.
9 Conlon KC, Urla WJ, Smith JW, Steis RG, Longo DL, Clark JW. Exacerbation of symptoms of autoimmune disease in patients receiving alpha interferon therapy. Cancer 1990; 65: 2237-42.
10 Lyint JA, Copplestone A, Orchard J, Craig V, Curtis D, Prentice AC, Hamon MD. Fludarabine-related autoimmune hemolytic anemia in patients with chronic lymphocytic leukemia. Br J Haematol 1995; 91: 341-4.